2021
DOI: 10.1089/jmf.2020.0129
|View full text |Cite
|
Sign up to set email alerts
|

Effects of the Use of Curcumin on Ulcerative Colitis and Crohn's Disease: A Systematic Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
36
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(38 citation statements)
references
References 51 publications
0
36
0
2
Order By: Relevance
“…Curcumin is able to modulate iron metabolism proteins, reducing the iron stores and restoring its physiological hematic level (81). Despite the description of clinical studies are beyond the scope of the present review, it should be noted that, to date, few clinical studies have been conducted to evaluate the clinical efficacy of curcumin (59,84).…”
Section: Inflammatory Bowel Diseasementioning
confidence: 96%
See 2 more Smart Citations
“…Curcumin is able to modulate iron metabolism proteins, reducing the iron stores and restoring its physiological hematic level (81). Despite the description of clinical studies are beyond the scope of the present review, it should be noted that, to date, few clinical studies have been conducted to evaluate the clinical efficacy of curcumin (59,84).…”
Section: Inflammatory Bowel Diseasementioning
confidence: 96%
“…There is some evidence that curcumin-containing supplements may exert anti-inflammatory and analgesic actions in patients with arthritis-related diseases and inflammatory bowel disease (59).…”
Section: O P Y R I G H T E D R a S P Amentioning
confidence: 99%
See 1 more Smart Citation
“…Another study on curcumin encapsulated with nanoparticles found it effective against colitis as it modulates GM and regulates T-cells [ 120 ]. The use of curcumin with randomized clinical trials showed therapeutic effects against ulcerative colitis and Crohn’s disease, but meta-analyses showed controversial results about the therapeutic approach [ 121 ]. Tetrahydrocurcumin can decrease the blood glucose level, increase the expression of pancreatic glucagon-like peptide-1, protect islet β cells, and the secretions of insulin in diabetic rats.…”
Section: Curcuminmentioning
confidence: 99%
“…Interestingly the highest percentage of improvement in the disease activity scores was observed in the curcumin group. Also the RCTs addressing the effect of curcumin on ulcerative colitis and Crohn’s Disease resulted in overall positive outcomes [ 70 ]. In the case of ulcerative colitis it could be shown that the efficacy of adjuvant curcumin therapy may be improved by using enhanced bioavailable formulations and prolonging intervention times [ 71 , 72 ].…”
Section: Curcumin: In Vitro Ic 50 Values Bioavailability and Clinical Efficacymentioning
confidence: 99%